feed,title,long_url,short_url
Benzinga,Infinity Pharma Posts 52% Increase In One-Year Progression Free Survival Rate In Breast Cancer Patients,https://benzinga.com/general/biotech/22/11/29704849/infinity-pharma-posts-52-increase-in-one-year-progression-free-survival-rate-in-breast-cancer-pat,https://bit.ly/3AdQq4K
Benzinga,Stoke Therapeutics Stock Falls Post Early Efficacy Data From Lead Dravet Syndrome Program,https://benzinga.com/general/biotech/22/11/29702966/stoke-therapeutics-stock-falls-post-early-efficacy-data-from-lead-dravet-syndrome-program,https://bit.ly/3EFrjKN
Benzinga,Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 53 Stocks Moving In Monday's Mid-Day Session,https://benzinga.com/news/22/11/29708256/why-opiant-pharmaceuticals-shares-are-trading-higher-by-115-here-are-53-stocks-moving-in-mondays-mid,https://bit.ly/3fYBZKY
